FDA approves Boehringer drug to treat advanced lung cancer

(Reuters) - The U.S. Food and Drug Administration approved a lung cancer drug made by Boehringer Ingelheim to treat patients who are suffering from late stage non-small cell lung cancer and whose tumors express a specific type of gene mutation.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/-l149JyHNXI/story01.htm

phlebotomy certification schools medical assistant schools phlebotomy schools in michigan